Ilika’s defence testing opens a new angle on solid-state battery value

Ilika Plc

Ilika’s latest update adds a different dimension to the investment case around its solid-state battery technology. Rather than focusing solely on future automotive or industrial uses, the company has highlighted how its large-format Goliath cells performed in defence-related testing designed to reflect battlefield conditions.

The key point from the testing is that a 10Ah Goliath cell was able to withstand an initial ballistic impact, with a thermal event only taking place after a second shot Battery developers often face a long path from laboratory promise to commercial credibility, particularly when safety is part of the core sales argument. Evidence that a cell can tolerate severe physical abuse without an immediate worst-case outcome may help support Ilika’s claim that solid-state chemistry can offer a more resilient safety profile in environments where failure tolerance is critical.

Any application where batteries are exposed to physical stress, operational uncertainty or strict safety thresholds could benefit from validation of this kind. Demonstrating a measured response under impact could therefore improve Ilika’s commercial conversation in sectors where risk management carries as much weight as raw battery capability.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Defence demand puts specialist battery technology in focus

Defence applications are increasing the need for specialist batteries that can deliver reliable power in demanding operating conditions.

Search